SENS.L Share News (SENS)
SENS Share
SENS Share
SENS Share
SENS Share
SENS
SENS Share
SENS Broker
SENS Directors
SENS Financial
SENS
SENS Short
SENSWed, 03rd Oct 2018 09:52
LONDON (Alliance News) - Sensyne Health PLC said Wednesday it appointed Lionel Tarassenko as non-executive director of the company.
Tarassenko is currently chairman of the company's Scientific Advisory Board. He is also a founding director of four spin-out companies from the University of Oxford and serves as a director for Oxford University Innovation Ltd and Oxehealth Ltd.
Shares in the clinical AI technology company were trading down 2% at 191.20 pence.
UK TRADING UPDATE SUMMARY: DWF Sets Up New Global Operating Structure
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreIN BRIEF: Sensyne Health Says Amount Raised Totals GBP27.5 Million
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreUK EXECUTIVE CHANGE SUMMARY: Cheshire Steps Down As Barclays UK Chair
Read moreUK TRADING UPDATE SUMMARY: Triple Point Social Ups Credit Facility
Read moreIN BRIEF: Sensyne Health Set To Complete Equity Raise With Open Offer
Read moreIN BRIEF: Sensyne Health Completes GBP24.6 Million Fundraise
Read moreIN BRIEF: Sensyne Health To Raise GBP28 Million, Partners With Phesi
Read moreUK TRADING UPDATE SUMMARY: SourceBio Tips Jump In Virus Testing Demand
Read more
(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed a five year non-exclusive strategic research agreement with Hampshire Hospitals NHS Foundation Trust, it announced on Wednesday.
Read moreIN BRIEF: Sensyne Health Achieves Five Million Patient Target
Read moreUK EXECUTIVE CHANGE SUMMARY: Shake-Up Of Primorus Board Continues
Read more(Sharecast News) - Clinical AI company Sensyne has tapped Derek Baird to take on the role of North American president as the group looks to advance its expansion into the region.
Read moreUK TRADING UPDATE SUMMARY: Sensyne App Used In Oxford Covid Study
Read more